Abstract:Zhenhu Zhang, 1, &ast Bin Shang, 1, &ast Xinyu Mao, 1 Yamin Shi, 2 Guodong Zhang, 1 Dong Wang 1 1 Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, People's Republic of China; 2 School of Foreign Languages, Shandong University of Finance and Economics, Jinan, 250014, People's Republic of China &astThese authors contributed equally to this work Correspondence: Dong Wang, Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jing Wu Road, Jinan, Shandong, 250021, People's Republic of China, Tel +8615168863605, Email Background: Esophageal squamous cell carcinoma (ESCC) is an aggressive and fatal malignancy that leads to epithelial cancer. The association between epithelial cell heterogeneity, prognosis, and immune response in this cancer remains uncertain. This study aimed to investigate epithelial cell heterogeneity in ESCC and develop a predictive risk model using the identified cell types. Methods: Single-cell RNA sequencing (scRNA-seq) and differential ESCC gene data were accessed from the Gene Expression Omnibus. Functional enrichment analysis, inferCNV, cell development trajectories, and intercellular communication were analyzed following epithelial cell characterization. Differentially expressed ESCC (n = 773) and epithelial cell marker genes (n = 3407) were intersected to obtain core genes, and epithelial cell-related prognostic genes were identified. LASSO regression analysis was used to construct a prognostic model. The external dataset GSE53624 was used to further validate the stability of the model. Drug sensitivity predictions, and immune cell infiltration were analyzed. Molecular docking clarified the possible therapeutic role of β-sitosterol in ESCC. Finally, wound healing assay, cell colony, and transwell assay were constructed to detect the effects of the core gene PDLIM2 on ESCC cell proliferation, invasion, and migration. Results: Eight cell clusters were identified, and epithelial cells were categorized into tumor and paratumor groups. The tumor group possessed more chromosomal variants than the paratumor group. Epithelial cells were associated with multiple cell types and significantly correlated with the Wnt, transforming growth factor, and epidermal growth factor signaling pathways. From 231 intersected genes, five core genes were screened for use in the risk model: CTSL, LAPTM4B, MYO10, NCF2, and PDLIM2. These genes may contribute to the cancerous transformation of normal esophageal epithelial cells and thereby act as biomarkers and potential therapeutic targets in patients with ESCC. β-Sitosterol furthermore displayed excellent docking potential with these genes. Meanwhile, further experiments demonstrated that the gene PDLIM2 plays a major role in the progression of oesophageal squamous carcinoma. Conclusion: We successfully developed a risk model for the prognosis of ESCC based on epithelial cells that addresses the response of ESCC to immunotherapy and offers novel cancer treatment options. Keywords: ESCC, epithelial cells, risk signature, β-sitosterol, TME Esophageal squamous cell carcinoma (ESCC) is a highly lethal cancer, with its highest incidence in Asia and Africa. 1 Despite considerable advances in esophageal cancer treatment over the past 10 years, the 5-year survival rate remains below 30%. 2 Surgery can treat such tumors successfully, but more than half of the patients with ESCC are in advanced stages and consequently ineligible for the procedure. Furthermore, the 5-year rates of metastasis and recurrence remain high (more than 40%), even after surgical treatment. 3 Chemotherapy can inhibit ESCC tumor growth and prevent distant metastasis but introduces unavoidable side effects such as toxicity and drug resistance. 4 Therefore, the search for safe and efficient alternative ESCC treatments remains crucial. The tumor microenvironment (TME) is closely associated with angiogenesis, apoptosis inhibition, immune system suppression, and surveillance evasion. 5 Numerous studies have demonstrated that intraepithelial neoplasia in normal epithelial cells leads to invasive carcinoma, which, in turn, stimulates ESCC development. 6 However, our understanding of the molecular pathways underlying ESCC pathogenesis in normal epithelial cells is limited. Several previous studies have focused on other cell types in ESCC; 7 however, the relationship between epithelial cell heterogeneity, ESCC prognosis, and immunotherapy response remains to be fully understood. Elucidating the tra -Abstract Truncated-

ESM1 May Be Used as a New Indicator for the Diagnosis and Prognosis of Early and Advanced Stage Digestive Tract Cancers

Stromal Interaction Molecule 1 Promotes Tumor Growth in Esophageal Squamous Cell Carcinoma.

Overexpression of Endothelial Cell Specific Molecule-1 (ESM-1) in Gastric Cancer

Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Regulated by KEAP1-NRF2 Pathway in Esophageal Carcinoma

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

76 WHOLE-EXOME SEQUENCING EXPLORES DIFFERENTIAL GENES EXPRESSION OF METASTASIS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PROPENSITY-SCORE MATCHING STUDY

Clinical Significance of Stanniocalcin-1 Detected in Peripheral Blood and Bone Marrow of Esophageal Squamous Cell Carcinoma Patients

Prognostic Risk Models Using Epithelial Cells Identify β-Sitosterol as a Potential Therapeutic Target Against Esophageal Squamous Cell Carcinoma

Targeting ESM1/ VEGFα signaling axis: a promising therapeutic avenue for angiogenesis in cervical squamous cell carcinoma

Development of biomarker signatures associated with anoikis to predict prognosis in patients with esophageal cancer: An observational study

APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis

Comprehensive molecular characterization and identification of prognostic signature in stomach adenocarcinoma on the basis of energy-metabolism-related genes

ESM1 facilitates the EGFR/HER3-triggered epithelial-to-mesenchymal transition and progression of gastric cancer via modulating interplay between Akt and angiopoietin-2 signaling

The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells

STC1 promotes esophageal squamous cell carcinoma progression and is associated with poor prognosis

Astrocyte Elevated Gene-1 As A Novel Clinicopathological And Prognostic Biomarker For Gastrointestinal Cancers: A Meta-Analysis With 2999 Patients

Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients

Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis

Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma

A bioinformatics analysis for diagnostic roles of the E2F family in esophageal cancer

Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance